Use of Antibodies In Small Animal Molecular Imaging - Sponsored Whitepaper

Use of Antibodies In Small Animal Molecular Imaging
Sponsored by:
Bruker BioSpin Corporation Logo
Bruker BioSpin Corporation
Download Entire Whitepaper
In vivo imaging, whether at the cellular or whole-animal level, promised to revolutionize preclinical and clinical biological and bioengineering research. By conducting longitudinal studies, the natural course of a disease or the experimental model can be monitored. Imaging modalities (such as X-ray, CT, MRI, optical, and ultrasound imaging) yield valuable information about changes in the anatomy and physiology of the specimen. In order to gain molecular information, animals were sacrificed, dissected, and studied via techniques such as immunoblotting (Western), immunofluorescence, immunohistochemistry, quantitative RT-PCR, microarray, HT sequencing, or FACS analysis. However, these techniques provide only information at the time of measurement, and because subjects of these techniques were often euthanized, longitudinal studies could not be completed. In addition, where and when to sample must be known beforehand, or a very large number of animals must be utilized.
Download Entire Whitepaper
Copyright © 2014, Questex Media Group LLC
Company descriptions and contact information are quoted from the company's website or other promotional information. Questex is not responsible for the accuracy of this information. Unless specifically noted, Questex is not sponsored by, affiliated with or otherwise connected with any of the listed companies.